Adzenys ER

12 stories · following the connections

Business

Neos Therapeutics to Host First Quarter 2018 Financial Results Conference Call on May 9, 2018

By Nasdaq OMXMay 2, 2018, 11:30 AM UTC

Business

Neos Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results

By Nasdaq OMXMar 15, 2018, 11:01 AM UTC

Business

Neos Therapeutics to Host Fourth Quarter and Year-End 2017 Financial Results Conference Call on March 15, 2017

By Nasdaq OMXMar 8, 2018, 12:30 PM UTC

Business

Neos Therapeutics to Present at the Cowen & Co. Annual Health Care Conference

By Nasdaq OMXMar 5, 2018, 1:01 PM UTC

Business

Neos Therapeutics Launches Adzenys ER™ (amphetamine) Extended-Release Oral Suspension in U.S. for the Treatment of ADHD in Patients 6 Years and Older

By Nasdaq OMXFeb 26, 2018, 1:00 PM UTC

Business

Neos Therapeutics to Present Three Posters at the Upcoming American Professional Society of ADHD and Related Disorders (APSARD) Annual Meeting

By Nasdaq OMXJan 10, 2018, 1:02 PM UTC

Business

Neos Therapeutics to Participate in Two December Conferences

By Nasdaq OMXNov 28, 2017, 1:01 PM UTC

Business

Neos Therapeutics Reports Third Quarter 2017 Financial Results

By Nasdaq OMXNov 8, 2017, 12:00 PM UTC